title: The influence of HLA matching and lymphocytotoxic antibody status in heart-lung allograft recipients receiving cyclosporin and azathioprine.
authors.affiliation: Harefield Hospital, Middlesex, Great Britain.
authors.forename: H
authors.initials: H
authors.lastname: Festenstein
authors.forename: N
authors.initials: N
authors.lastname: Banner
authors.forename: J
authors.initials: J
authors.lastname: Smith
authors.forename: J
authors.initials: J
authors.lastname: Awad
authors.forename: M
authors.initials: M
authors.lastname: Burden
authors.forename: N
authors.initials: N
authors.lastname: Fitzgerald
authors.forename: J
authors.initials: J
authors.lastname: Holmes
authors.forename: A
authors.initials: A
authors.lastname: Khaghani
authors.forename: J
authors.initials: J
authors.lastname: Smith
authors.forename: D
authors.initials: D
authors.lastname: McCloskey
mesh_terms: D000017:ABO Blood-Group System; D001379:Azathioprine / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D003601:Cytotoxicity Tests, Immunologic; D006085:Graft Survival / Q000187:drug effects; D006680:HLA Antigens / Q000032:analysis*; D015234:HLA-A Antigens / Q000032:analysis; D006684:HLA-DR Antigens / Q000032:analysis; D016027:Heart Transplantation; D016041:Heart-Lung Transplantation; D006650:Histocompatibility Testing; D006801:Humans; D016040:Lung Transplantation; D011379:Prognosis; D014184:Transplantation, Homologous
chemical_list: D000017:ABO Blood-Group System; D003524:Cyclosporins; D006680:HLA Antigens; D015234:HLA-A Antigens; D006684:HLA-DR Antigens; D001379:Azathioprine